Consensus EPS · Q4 2026
$1.65
Consensus revenue · Q4 2026
$1.9B
Analysts
11
Expected report
Aug 3, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 11 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.9B | $1.9B | $2B |
| EPS | $1.59 | $1.65 | $1.71 |
| EBITDA | $397.1M | $403.4M | $407.7M |
| EBIT | $333.9M | $339.3M | $342.8M |
| Net income | $182M | $200.6M | $271.3M |
- Revenue$1.9B
- EPS$1.65
- EBITDA$403.4M
- EBIT$339.3M
- Net income$200.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $1.7B | $1.7B | 0.0% | $1.64 | $1.55 | +6.0% |
- Q3 20260.0%+6.0%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $1.9B | $1.9B | — | — | +0.5% |
| EPS | $1.42 | $1.46 | — | — | -2.4% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Clorox (CLX) Q4 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 1 analyst.
- Low
- $83.00
- Consensus
- $105.80
- Median
- $103.50
- High
- $139.00
- Current
- $95.76
- Upside
- +10.5%
Upside calculated vs most recent trading price of $95.76.
Analyst ratings
Consensus: Hold — based on 29 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2026 | BNP Paribas | maintain | Neutral | Neutral |
| Jul 16, 2026 | UBS | maintain | Neutral | Neutral |
| Jul 16, 2026 | JP Morgan | maintain | Underweight | Underweight |
| May 18, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| May 4, 2026 | Barclays | maintain | Underweight | Underweight |
| May 1, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| May 1, 2026 | UBS | maintain | Neutral | Neutral |
| May 1, 2026 | JP Morgan | maintain | Underweight | Underweight |
| May 1, 2026 | Evercore ISI Group | maintain | Underperform | Underperform |
| May 1, 2026 | Citigroup | maintain | Neutral | Neutral |
- Jul 20, 2026BNP ParibasNeutral
- Jul 16, 2026UBSNeutral
- Jul 16, 2026JP MorganUnderweight
- May 18, 2026Wells FargoEqual Weight
- May 4, 2026BarclaysUnderweight
- May 1, 2026Wells FargoEqual Weight
- May 1, 2026UBSNeutral
- May 1, 2026JP MorganUnderweight
- May 1, 2026Evercore ISI GroupUnderperform
- May 1, 2026CitigroupNeutral
Frequently asked questions
Clorox (CLX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.63% TTM
- Dividend Profile5.18% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.